British Study: Home Care Matches Dialysis Outcomes for Older Patients

A landmark British study has found that for older people with kidney failure, managing symptoms at home can offer the same length and quality of life as dialysis, challenging decades of default medical practice.

The nine-year randomized trial, led by the University of Bristol, tracked nearly 500 patients, most over 80, and found no survival advantage for those who began the grueling routine of hospital dialysis three times a week compared with those who chose a structured program of “responsive management” at home. Participants in both groups were more likely to die from other conditions — heart disease, cancer — than from kidney failure itself.

“Neither treatment option was superior to the other, but both provided similar overall length and quality of life,” said Fergus Caskey, a kidney consultant at Bristol NHS Foundation Trust and the project lead. “Our findings could have global implications for how kidney failure is discussed and managed in older patients.”

British Study: Home Care Matches Dialysis Outcomes for Older Patients
Photo: aol.com

Dialysis keeps younger patients alive. For someone in their 80s, often living with multiple other illnesses, the calculus shifts. The treatment typically demands four-hour sessions in a hospital unit three days a week — “a huge undertaking,” in Caskey’s words, and one that can be “very exhausting.” Older people generally do not recover kidney function or come off dialysis once they start.

The study, which Caskey described as the first randomized trial of its kind in the world, allocated patients to either prepare for dialysis or prepare for responsive management at home. Over an average follow-up of 4.5 years, the outcomes converged.

The data suggests that for this frail population, the hours spent in transit and in a dialysis chair may not buy extra time — they may only buy a different kind of difficulty.

Treatment options for older people with kidney failure: the Prepare for Kidney Care study results — Bristol NHS Foundation Trust

Lynn Watts, 77, from Kingswood in South Gloucestershire, entered the trial in January 2024. She had decided she would accept dialysis if her symptoms worsened, but she dreaded losing three days a week to the hospital.

She was randomized to the non-dialysis arm. “It’s slowed my life down,” she told BBC News. “I’m not running about and doing gardening… like I used to. I’m still alive and that’s how I look at it.”

“It’s slowed my life down. I’m not running about and doing gardening… like I used to. I’m still alive and that’s how I look at it.”

— Lynn Watts, trial participant

Fiona Loud of the charity Kidney Care UK said the research offers a chance to weigh “the balance of the treatment versus what you might value most… towards the end of your life.”

There are 7.2 million people in the UK with some level of chronic kidney disease, the charity notes, though most are at early stages. For the fraction who reach failure in very old age, the study hands them something rare: evidence to choose.

“Patients should be told the pros and cons of both treatments and supported to make the choice that fits their priorities for care,” Caskey said.